Article
Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy.
The Journal of biological chemistry - 14 Jun 2002
Zhang Mingyu, Smith Eric P, Kuroda Hiroaki, Banach Walter, Chernausek Steven D, Fagin James A
Abstract excerpt
The insulin-like growth factor-binding protein 4 (IGFBP-4), the most abundant IGF-binding protein produced by rodent smooth muscle cells (SMC), is degraded by specific protease(s) potentially releasing IGF-I for local bioactivity. IGFBP-4 protease(s) recognizes basic residues within the midregion of the molecule. We constructed a mutant IGFBP-4 with the cleavage domain substitution 119-KHMAKVRDRSKMK-133 to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
